Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

Intravenous immunoglobulins are an efficacious treatment for chronic inflammatory demyelinating polyradiculoneuropathy. Biomarkers for disease activity are lacking, making the need for ongoing treatment difficult to assess, leading to potential overtreatment and high health-care costs. Our objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrichem, Max E., Lucke, Ilse M., Vrancken, Alexander F. J. E., Goedee, H. Stephan, Wieske, Luuk, Dijkgraaf, Marcel G. W., Voermans, Nicol C., Notermans, Nicolette C., Faber, Catharina G., Visser, Leo H., Kuitwaard, Krista, van Doorn, Pieter A., Merkies, Ingemar S. J., de Haan, Rob J., van Schaik, Ivo N., Eftimov, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166547/
https://www.ncbi.nlm.nih.gov/pubmed/35139161
http://dx.doi.org/10.1093/brain/awac054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166547/
https://www.ncbi.nlm.nih.gov/pubmed/35139161
http://dx.doi.org/10.1093/brain/awac054

Ejemplares similares